Cite
HARVARD Citation
Padden-Modi, M. et al. (n.d.). PO-1242 Clinical, pathological and dosimetric factors influencing outcomes in NSCLC treated with SABR. Radiotherapy and oncology. pp. S1048-S1050. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Padden-Modi, M. et al. (n.d.). PO-1242 Clinical, pathological and dosimetric factors influencing outcomes in NSCLC treated with SABR. Radiotherapy and oncology. pp. S1048-S1050. [Online].